Rule of the local flow redistribution when node <i>i</i> fails. by Jinqiang Xu (5677835)

Subjects:

Thresholds for these levels of the nodal vulnerability. by Jinqiang Xu (5677835)

Subjects:

Freeway network of case study. by Jinqiang Xu (5677835)

Subjects:

Location and length of the tunnels in the FFN. by Jinqiang Xu (5677835)

Subjects:

Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3‑Oxo-3,4-dihydro‑2<i>H</i>‑ben... by Shuhei Ikeda (2380180)

Subjects:

RDA analysis of environmental factors and fungal community composition (A), diversity (B). by Xiaoqing Li (186909)

50 year old female with Libman-Sacks endocarditis complicated with an acute transient ischemic attack, past stroke, and seizure disorder. by Carlos A. Roldan (10151007)

Current responses of different ChR variants to light steps of increasing intensities. by Marion Mutter (490174)

“…<p>In each panel, we show the light responses of a certain variant of ChR to 8 different 1-sec light steps of increasing intensity (top). At the beginning of each light step, the model was set to its basic state (<i>C</i>₁ = 1, <i>O</i>₁ = <i>C</i>₂ = <i>O</i>₂ = 0). …”

Selective TASK‑1 Inhibitor with a Defined Structure–Activity Relationship Reduces Cancer Cell Proliferation and Viability by Bárbara Arévalo (4053358)

“…Mutation of seven residues to A (I118A, L122A, F125A, Q126A, L232A, I235A, and L239A) markedly decreased the F3-induced inhibition of TASK-1 channels, consistent with the molecular modeling predictions. …”

Selective TASK‑1 Inhibitor with a Defined Structure–Activity Relationship Reduces Cancer Cell Proliferation and Viability by Bárbara Arévalo (4053358)

“…Mutation of seven residues to A (I118A, L122A, F125A, Q126A, L232A, I235A, and L239A) markedly decreased the F3-induced inhibition of TASK-1 channels, consistent with the molecular modeling predictions. …”

Cesarean section rate 2003-2017 among HSJ, control and Denmark. by Eva Rydahl (6260771)

Subjects:

Baseline characteristics for HSJ, control and Denmark (without HSJ) in the preintervention period, N = 289.045. by Eva Rydahl (6260771)

Subjects:

Change in maternal characteristics during 2003–2017, HSJ and control. by Eva Rydahl (6260771)

Subjects:

Time series comparing trends at HSJ and control hospitals in the pre-intervention and intervention period. Significance test determine if trends differ between groups. by Eva Rydahl (6260771)

Subjects:

Cesarean section. by Eva Rydahl (6260771)

Subjects:

Flow chart of study participants. by Eva Rydahl (6260771)

Subjects:

Timeseries analyses HSJ trend before- and during intervention. by Eva Rydahl (6260771)

Subjects:

Absolute numbers among CS groups. by Eva Rydahl (6260771)

Subjects:

HSJ and controls stratified by timing for CS and parity. by Eva Rydahl (6260771)

Subjects:

LPS administration demonstrated a significant decrease in the protein expression of both claudin-1 and occludin in BF fed mice as compared to control mice. by Valentina Di Caro (510473)